GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
Found partners exclusively with licensed 503A compounding pharmacies
Reduced caloric and protein intake: Zepbound significantly reduces appetite, which is central to its weight loss mechanism
Hamel, KFF Health Tracking Poll May 2024: The Publics Use and Views of GLP-1 Drugs
Your results are much more likely to be influenced by taking the medication consistently, reaching the appropriate dose with your healthcare provider, and maintaining healthy lifestyle habits than by which approved injection site you choose